Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy

IMPORTANCE: Patients with advanced soft-tissue sarcomas (STS) have a median overall survival of less than 18 months. Identification of molecular abnormalities for which targeted therapies are available or can be developed is critical for improving patient outcomes. OBJECTIVE: To characterize targeta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Oncol
Hlavní autoři: Lucchesi, Carlo, Khalifa, Emmanuel, Laizet, Yec’han, Soubeyran, Isabelle, Mathoulin-Pelissier, Simone, Chomienne, Christine, Italiano, Antoine
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2018
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233783/
https://ncbi.nlm.nih.gov/pubmed/29801054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0723
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky